Hologic (HOLX) shares undervalued - Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500, Dow futures dip as big banks' earnings roll in ahead of CPI data; IBM slides
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Needham & Company Upgrades Hologic (HOLX) to Buy as COVID-related headwind will soon end
July 14, 2023 6:51 AM EDT(Updated - July 14, 2023 7:48 AM EDT)
Needham & Company analyst Mike Matson upgraded Hologic (NASDAQ: HOLX) from Hold to Buy with a price target of $95.00.
The analyst commented, "We are upgrading HOLX shares to Buy from Hold. We think the... More
